» Articles » PMID: 35704480

Chapare Hemorrhagic Fever and Virus Detection in Rodents in Bolivia in 2019

Abstract

Background: In June 2019, the Bolivian Ministry of Health reported a cluster of cases of hemorrhagic fever that started in the municipality of Caranavi and expanded to La Paz. The cause of these cases was unknown.

Methods: We obtained samples for next-generation sequencing and virus isolation. Human and rodent specimens were tested by means of virus-specific real-time quantitative reverse-transcriptase-polymerase-chain-reaction assays, next-generation sequencing, and virus isolation.

Results: Nine cases of hemorrhagic fever were identified; four of the patients with this illness died. The etiologic agent was identified as , or Chapare virus (CHAPV), which causes Chapare hemorrhagic fever (CHHF). Probable nosocomial transmission among health care workers was identified. Some patients with CHHF had neurologic manifestations, and those who survived had a prolonged recovery period. CHAPV RNA was detected in a variety of human body fluids (including blood; urine; nasopharyngeal, oropharyngeal, and bronchoalveolar-lavage fluid; conjunctiva; and semen) and in specimens obtained from captured small-eared pygmy rice rats (). In survivors of CHHF, viral RNA was detected up to 170 days after symptom onset; CHAPV was isolated from a semen sample obtained 86 days after symptom onset.

Conclusions: was identified as the etiologic agent of CHHF. Both spillover from a zoonotic reservoir and possible person-to-person transmission were identified. This virus was detected in a rodent species, . (Funded by the Bolivian Ministry of Health and others.).

Citing Articles

Chapare virus hemorrhagic fever in Bolivia, 2020-2025.

Escalera-Antezana J, Montesinos-Jove R, Gonzales-Flores C, Arauco-Gutierrez C, Aviles-Sarmiento J, Montenegro-Narvaez C New Microbes New Infect. 2025; 64:101569.

PMID: 40070948 PMC: 11894320. DOI: 10.1016/j.nmni.2025.101569.


Viral diversity in wild rodents in the regions of Canaã de Carajás and Curionopólis, State of Pará, Brazil.

Monteiro A, da Silva F, Cruz A, da Silva S, Queiroz A, Casseb L Front Microbiol. 2025; 15():1502462.

PMID: 39839123 PMC: 11747277. DOI: 10.3389/fmicb.2024.1502462.


Delayed low-dose oral administration of 4'-fluorouridine inhibits pathogenic arenaviruses in animal models of lethal disease.

Welch S, Spengler J, Westover J, Bailey K, Davies K, Aida-Ficken V Sci Transl Med. 2024; 16(774):eado7034.

PMID: 39565871 PMC: 11875022. DOI: 10.1126/scitranslmed.ado7034.


Understanding Viral Haemorrhagic Fevers: Virus Diversity, Vector Ecology, and Public Health Strategies.

Hewson R Pathogens. 2024; 13(10).

PMID: 39452780 PMC: 11510013. DOI: 10.3390/pathogens13100909.


Analysis of early warning indicators of death in patients with severe fever with thrombocytopenia syndrome.

Yang M, Yin M, Hou B, Zhou L, Wang J, Zhao Z BMC Infect Dis. 2024; 24(1):765.

PMID: 39090556 PMC: 11293107. DOI: 10.1186/s12879-024-09599-0.


References
1.
Peters C, KUEHNE R, Mercado R, Le Bow R, SPERTZEL R, WEBB P . Hemorrhagic fever in Cochabamba, Bolivia, 1971. Am J Epidemiol. 1974; 99(6):425-33. DOI: 10.1093/oxfordjournals.aje.a121631. View

2.
Veliziotis I, Roman A, Martiny D, Schuldt G, Claus M, Dauby N . Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020. Emerg Infect Dis. 2020; 26(7):1562-1566. PMC: 7323566. DOI: 10.3201/eid2607.200275. View

3.
Ezeomah C, Adoga A, Ihekweazu C, Paessler S, Cisneros I, Tomori O . Sequelae of Lassa Fever: Postviral Cerebellar Ataxia. Open Forum Infect Dis. 2019; 6(12):ofz512. PMC: 6923636. DOI: 10.1093/ofid/ofz512. View

4.
. Bolivian hemorrhagic fever--El Beni Department, Bolivia, 1994. MMWR Morb Mortal Wkly Rep. 1994; 43(50):943-6. View

5.
Carroll D, Mills J, Montgomery J, Bausch D, Blair P, Burans J . Hantavirus pulmonary syndrome in Central Bolivia: relationships between reservoir hosts, habitats, and viral genotypes. Am J Trop Med Hyg. 2005; 72(1):42-6. View